The epidemiology of hepatocellular cancer in Poland

Dariusz Wasiak; Jacek Pliszczyński; Beata Łągiewska; Maurycy Jonas; Mariusz Panczyk; Piotr Małkowski; Wojciech Lisik; Maciej Kosieradzki

doi:10.5114/ceh.2018.73669

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2018
vol. 4

Send email

Copy url:

abstract:

Original paper

The epidemiology of hepatocellular cancer in Poland

Dariusz Wasiak

,

Jacek Pliszczyński

,

Beata Łągiewska

,

Maurycy Jonas

,

Mariusz Panczyk

,

Piotr Małkowski

,

Wojciech Lisik

,

Maciej Kosieradzki

Clin Exp HEPATOL 2018; 4, 1: 13-27

DOI: https://doi.org/10.5114/ceh.2018.73669

Online publish date: 2018/02/09

View full text Get citation

PlumX metrics:

Introduction
This article summarize the available data on hepatocellular carcinoma (HCC) epidemiology in Poland. Data regarding the HCC incidence rate are divergent. Statistical data presented by NFZ appear more credible in that matter than data published by the Polish Oncology Center (POC).

Material and methods
The analysis included data from the Polish Bibliography Database (GBL), the Polish National Health Fund Institution (NFZ), the scientific paper “Malignant neoplasms in Poland” issued by POC and the central liver transplant registry maintained by the Polish transplant coordinating center “Poltransplant” (2010-2015).

Results
Data regarding the HCC incidence rate are divergent. Statistical data presented by NFZ appear more credible in that matter than data published by POC.

Conclusions
The occurrence of HCC in Poland is at the average European level and is similarly rising. The incidence rate is underestimated. It is due to faulty epidemiology data collection techniques. The highest risk group comprises men over the age of 50 with concomitant liver cirrhosis. The most common HCC etiology is HCV infection.

keywords:

The epidemiology of hepatocellular cancer in Poland

Dariusz Wasiak , Jacek Pliszczyński , Beata Łągiewska , Maurycy Jonas , Mariusz Panczyk , Piotr Małkowski , Wojciech Lisik , Maciej Kosieradzki

liver transplantation, hepatocellular carcinoma, chronic liver disease

Dariusz Wasiak

,

Jacek Pliszczyński

,

Beata Łągiewska

,

Maurycy Jonas

,

Mariusz Panczyk

,

Piotr Małkowski

,

Wojciech Lisik

,

Maciej Kosieradzki